The effects of dexamethasone and chlorpromazine on tumour necrosis factor-α, interleukin-1β, interleukin-1 receptor antagonist and interleukin-10 in human volunteers

Immunology

Volumn 91, Issue 4, 1997, Pages 548-552

  Bleeker, M W P ^a   Netea, M G ^a   Kullberg, B J ^a   Van Der Ven Jongekrijg, J ^a   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DEXAMETHASONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030759353     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00285.x     Document Type: Article

References (25)

1. PARILLO J.E. (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328, 1471.
2. BEUTLER B., MILSARK I.W. & CERAMI A.C. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869.
3. TRACEY K.J., FONG Y., HESSE D.G. et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662.
4. WAKABAYASHI G., GELFAND J.A., BURKE J.F., THOMSON R.C. & DINARELLO C.A. (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5, 338.
5. WAAGE A. & BAKKE O. (1988) Glucocorticoids suppress production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63, 299.
6. KERN J.A., LAMB R.J., REED J.C., DANIELE R.P. & NOWELL P.C. (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81, 237.
7. BERTINI R., BIANCHI M. & GHEZZI P. (1988) Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 167, 1708.
8. GADINA M., BERTINI R., MENGOZZI M., ZANDALASINI M., MANTOVANI A. & GHEZZI P. (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 173, 1305.
9. GATTI S., FAGGIONI R., ECHTENACHER B. & GHEZZI P. (1993) Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 91, 456.
10. BARBER A.E., COYLE S.M., MARANO M.A. et al. (1993) Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150, 1999.
11. NETEA M.G., BLOK W.L., KULLBERG B.J. et al. (1995) Pharmacologie inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxaemia and in infection with live microorganisms in mice. J Infect Dis 171, 393.
12. ZINETTI M., GALLI G., DEMITRI M.T. et al. (1995) Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro. Immunology 86, 416.
13. MENGOZZI M., FANTUZZI G., FAGGIONI R. et al. (1994) Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82, 207.
14. TARAZONA R., GONZALEZ-GARCIA A., ZAMZAMI N. et al. (1995) Chlorpromazine amplifies macrophage-dependent IL-10 production in vim. J Immunol 154, 861.
15. DRENTH J.P.H., VAN UUM S.H.M., VAN DEUREN M., PESMAN G.J., VAN DER VEN-JONGEKRIJG J. & VAN DER MEER J.W.M. (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 79, 1497.
16. VAN DEUREN M., VAN DER VEN-JONGEKRIJG J., KEUTER M., DEMACKER P.N.M. & VAN DER MEER J.W.M. (1993) Cytokine production in whole blood cultures. J Int Fed Clin Chem 5, 216.
17. ENDRES S., GHORBANI R., LONNEMANN G., VAN DER MEER J.W.M. & DINARELLO C.A. (1988) Measurement of immunoreactive interleukin-1β from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clin Immunol Immunopathol 49, 424.
18. SCHEINMAN R.I., COGSWELL P.C., LOFQUIST A.K. & BALDWIN A.S. (1995) Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 270, 283.
19. SANTOS A.A., SCHELTINGA M.R., LYNCH E. et al. (1993) Elaboration of interleukin-1 receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg 128, 138.
20. BARBER A.E., COYLE S.M., FISCHER E. et al. (1995) Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 118, 406.
21. SAUER J., CASTREN M., HOPFNER U., HOLSBOER F., SATLLA G.K. & ARZT E. (1996) Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab 81, 73.
22. MARTINEZ F. & COLEMAN J.W. (1989) The effects of selected drugs, including chlorpromazine and non-steroidal antiinflammatory agents, on polyclonal IgG synthesis and interleukin I production by human peripheral blood mononuclear cells in vitra. Clin Exp Immunol 76, 252.
23. BERTINI R., GARATTINI S., DELGADO R. & GHEZZI P. (1993) Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 79, 217.
24. SCHLEUNING M.J., DUGGAN A. & REEM G.H. (1989) Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes. Eur J Immunol 19, 1491.
25. MORSELLI P.L. (1977) Psychotropic drugs. In: Drug Disposition During Development (ed. P.L. Morselli), p. 431. Spectrum Publications Inc., New York.